Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Linda Bethea details how the marketer of brands including Oikos and Silk is approaching emerging channels and artificial ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide reduces the risk of heart attack, stroke, and cardiovascular death by 14% in patients with type 2 ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

For individuals with type 1 diabetes, low-glucose alerts improve the time below range for drivers and reduce the incidence of low glucose while driving.

It can boost insulin efficiency, lead to weight loss and protect the liver Dubai: Fasting during Ramadan can be a simple, natural way to help control Type 2 diabetes, according to a healthcare expert.

You may have a higher risk of tooth decay and gum disease when you live with diabetes. Your dentist and oral care team may also recognize diabetes symptoms based on your teeth and gum health.